Literature DB >> 21314817

Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α.

Fiona M Keane1, Naveed A Nadvi, Tsun-Wen Yao, Mark D Gorrell.   

Abstract

Fibroblast activation protein-α (FAP) is a cell surface-expressed and soluble enzyme of the prolyl oligopeptidase family, which includes dipeptidyl peptidase 4 (DPP4). FAP is not generally expressed in normal adult tissues, but is found at high levels in activated myofibroblasts and hepatic stellate cells in fibrosis and in stromal fibroblasts of epithelial tumours. FAP possesses a rare catalytic activity, hydrolysis of the post-proline bond two or more residues from the N-terminus of target substrates. α(2)-antiplasmin is an important physiological substrate of FAP endopeptidase activity. This study reports the first natural substrates of FAP dipeptidyl peptidase activity. Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY were the most efficiently hydrolysed substrates and the first hormone substrates of FAP to be identified. In addition, FAP slowly hydrolysed other hormone peptides, such as the incretins glucagon-like peptide-1 and glucose-dependent insulinotropic peptide, which are efficient DPP4 substrates. FAP showed negligible or no hydrolysis of eight chemokines that are readily hydrolysed by DPP4. This novel identification of FAP substrates furthers our understanding of this unique protease by indicating potential roles in cardiac function and neurobiology.
© 2011 The Authors Journal compilation © 2011 FEBS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21314817     DOI: 10.1111/j.1742-4658.2011.08051.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  42 in total

1.  Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets.

Authors:  Petr Busek; Petr Hrabal; Premysl Fric; Aleksi Sedo
Journal:  Histochem Cell Biol       Date:  2014-11-02       Impact factor: 4.304

2.  A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy.

Authors:  Brynn B Duncan; Steven L Highfill; Haiying Qin; Najat Bouchkouj; Shannon Larabee; Peng Zhao; Iwona Woznica; Yuxin Liu; Youhua Li; Wengen Wu; Jack H Lai; Barry Jones; Crystal L Mackall; William W Bachovchin; Terry J Fry
Journal:  J Immunother       Date:  2013-10       Impact factor: 4.456

Review 3.  The role of fibroblast activation protein in health and malignancy.

Authors:  Allison A Fitzgerald; Louis M Weiner
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer.

Authors:  Kate Lawrenson; Barbara Grun; Nathan Lee; Paulette Mhawech-Fauceglia; Jenny Kan; Steve Swenson; Yvonne G Lin; Tanja Pejovic; Joshua Millstein; Simon A Gayther
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

5.  Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold.

Authors:  Koen Jansen; Leen Heirbaut; Jonathan D Cheng; Jurgen Joossens; Oxana Ryabtsova; Paul Cos; Louis Maes; Anne-Marie Lambeir; Ingrid De Meester; Koen Augustyns; Pieter Van der Veken
Journal:  ACS Med Chem Lett       Date:  2013-03-18       Impact factor: 4.345

Review 6.  The expression of proline-specific enzymes in the human lung.

Authors:  Gwendolyn Vliegen; Tom K Raju; Dirk Adriaensen; Anne-Marie Lambeir; Ingrid De Meester
Journal:  Ann Transl Med       Date:  2017-03

7.  Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity.

Authors:  Lesley Baerts; Raf Brouns; Kaat Kehoe; Robert Verkerk; Sebastiaan Engelborghs; Peter Paul De Deyn; Dirk Hendriks; Ingrid De Meester
Journal:  Transl Stroke Res       Date:  2016-08-26       Impact factor: 6.829

8.  Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations.

Authors:  M M Koczorowska; S Tholen; F Bucher; L Lutz; J N Kizhakkedathu; O De Wever; U F Wellner; M L Biniossek; A Stahl; S Lassmann; O Schilling
Journal:  Mol Oncol       Date:  2015-08-11       Impact factor: 6.603

Review 9.  Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?

Authors:  Ellen Puré; Albert Lo
Journal:  Cancer Immunol Res       Date:  2016-04       Impact factor: 11.151

10.  Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics.

Authors:  Hui Emma Zhang; Elizabeth J Hamson; Maria Magdalena Koczorowska; Stefan Tholen; Sumaiya Chowdhury; Charles G Bailey; Angelina J Lay; Stephen M Twigg; Quintin Lee; Ben Roediger; Martin L Biniossek; Matthew B O'Rourke; Geoffrey W McCaughan; Fiona M Keane; Oliver Schilling; Mark D Gorrell
Journal:  Mol Cell Proteomics       Date:  2018-09-26       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.